Advertisement
Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc. (KYTX) Stock Overview

Explore Kyverna Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

KYTX●NASDAQ
HealthcareBiotechnology
$7.82
$0.08(1.01%)
U.S. Market is Open · 13:56
Advertisement

Kyverna Therapeutics, Inc. (KYTX)

Meyka AI Score

Z

Key Financials

Market Cap342.5M
P/E Ratio-3.00
EPS (TTM)$-3.27
ROE-0.82%
Fundamental Analysis

AI Price Forecasts

1 Month$7.81
3 Months$8.26
1 Year Target$12.73

KYTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kyverna Therapeutics, Inc. (KYTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.00 and a market capitalization of 342.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.01%
5-Day Change
-9.07%
1-Month Change
-11.84%
3-Month Change
-2.49%
6-Month Change
8.91%
Year-to-Date (YTD) Change
-16.81%
1-Year Change
180.29%
3-Year Change
-73.93%
5-Year Change
-73.93%
All-Time (Max) Change
-73.93%

Contact Information

https://kyvernatx.com
(510) 925-2492
5980 Horton Street, Emeryville, CA, 94608

Company Facts

112 Employees
IPO DateFeb 9, 2024
CountryUS
Actively Trading

Frequently Asked Questions